It has been a mixed year for Outset Medical, Inc. insiders: $870,000 bought by one person and $369,000 sold by five, so more buying than selling overall.
Leonard Braden Michael (10% Owner) made the biggest buy, worth around $806,000.
On the institutional side, 93 funds reported holding OM at the end of Q2 2026, and funds were split between buying and selling. 7 quarters in a row of net selling by insiders. Insiders bought in 0 of the last 7 full quarters. This quarter so far: net buying.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Leonard Braden Michael | 10% Owner | Buy | 16,575 | $3.88 | $64K | SEC |
| Oct 5, 2026 | Leonard Braden Michael | 10% Owner | Buy | 228,334 | $3.53 | $806K | SEC |
| Aug 18, 2026 | Trigg Leslie | CEO | Sell | 3,437 | $4.39 | $15K | SEC |
| Aug 18, 2026 | Brottem John L. | Executive Officer | Sell | 2,632 | $4.39 | $12K | SEC |
| Aug 18, 2026 | Gaeta Renee | CFO | Sell | 4,543 | $4.39 | $20K | SEC |
| Jun 5, 2026 | Gaeta Renee | CFO | Sell | 17,672 | $4.94 | $87K | SEC |
| May 19, 2026 | Trigg Leslie | CEO | Sell | 3,445 | $3.70 | $13K | SEC |
| May 19, 2026 | Nash Marc | Executive Officer | Sell | 1,582 | $3.70 | $6K | SEC |
| May 19, 2026 | Brottem John L. | Executive Officer | Sell | 2,638 | $3.70 | $10K | SEC |
| Feb 19, 2026 | Brottem John L. | Executive Officer | Sell | 2,842 | $3.35 | $10K | SEC |
| Feb 19, 2026 | Trigg Leslie | CEO | Sell | 3,361 | $3.35 | $11K | SEC |
| Feb 19, 2026 | Nash Marc | Executive Officer | Sell | 1,817 | $3.35 | $6K | SEC |
| Jan 21, 2026 | Nash Marc | Executive Officer | Sell | 980 | $4.98 | $5K | SEC |
| Jan 21, 2026 | Brottem John L. | Executive Officer | Sell | 9,314 | $5.12 | $48K | SEC |
| Jan 21, 2026 | Trigg Leslie | CEO | Sell | 11,794 | $5.12 | $60K | SEC |
In the last 12 months Outset Medical, Inc. insiders made open-market purchases worth about $870,000 and sales worth about $369,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in OM was filed on 2026-10-05.
93 investment managers reported holding OM in SEC Form 13F filings for Q2 2026.
No congressional trades in OM were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).